The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.
Messaoudene M, Ferreira S, Saint-Lu N, Ponce M, Truntzer C, Boidot R, Le Bescop C, Loppinet T, Corbel T, Féger C, Bertrand K, Elkrief A, Isaksen M, Vitry F, Sablier-Gallis F, Andremont A, Bod L, Ghiringhelli F, de Gunzburg J, Routy B.
Messaoudene M, et al. Among authors: corbel t.
Nat Commun. 2024 Sep 15;15(1):8083. doi: 10.1038/s41467-024-52373-8.
Nat Commun. 2024.
PMID: 39278946
Free PMC article.
Clinical Trial.